Youll see amazing results in just 7 days
plans to take part in the Trump administrations drug pricing model that seeks to expand access to diabetes and obesity treatments covered under Medicare and Medicaid
This could give it broader therapeutic potential for: As of 2025, Dihexa has not yet entered large-scale, double-blind, placebo-controlled clinical trials for widespread human use
Metformin, a first-line T2DM treatment, affects the gastrointestinal tract by altering glucose uptake, GLP-1 secretion, gut microbiota, and immune response [33, 34], but it rarely causes bowel obstruction
Adipose tissue contributes to a chronic low-grade inflammation in PCOS through elevated inflammatory cytokines, including tumor necrosis factor alpha, transforming growth factor beta, interleukin 6, and interleukin 1 beta